By Shirley S. Wang
iStockphoto
Here’s what’s making health news this morning:
No Easy Cure for Diabetic Children (WSJ): A government-funded study looking at three different drug regimens for treating Diabetes 2 in children found metformin, a drug that’s long been used and considered effective in adults, to work relatively poorly in children.
Warner Chilcott Said to Consider Options After Interest (Bloomberg): The Dublin-based drug maker, which had $2.7 billion in revenue last year, is considering its options after strategic and private-equity buyers showed interest, people familiar with the matter told Bloomberg.
Actelion Breathes Easy on ‘Best Case’ New Drug Data (Reuters): The large European biotech announced positive Phase III data for a new drug to treat pulmonary arterial hypertension, better than many investors expected.
With Support Off as Events Begin, Komen Works to Revive Its Image (NY Times): The cancer-advocacy organization is trying to rebound from recent hits on its reputation, particularly at the level of its local affiliates.
‘Weapons of Persuasion’ from Robert Cialdini (Los Angeles Times): Research by the professor emeritus of psychology at Arizona State University and author of “Influence: The Psychology of Persuasion,” has identified six techniques to win people over.
